Hemodynamic Homeostasis · §13 · reject(operating point) → side-effect class; reset(reference) → durable

The comfort principle: counter-regulation is the structural origin of the side-effect class

The comfort principle is structural: an operating-point antihypertensive is rejected back to the defended reference by the kidney integral controller (durable drop 0 mmHg), and that rejection is the structural origin of the antihypertensive side-effect class. A reference-reset direction is not rejected (durable drop 17 mmHg) [V].

This volume imports the three-lever intervention technique from the non-opioid analgesic whitepaper (concept DOI 10.5281/zenodo.20733420) and applies it to the defended arterial-pressure setpoint. The package already proved that the pressure loop is an integral controller that rejects operating-point pushes back to its reference (RP4) while a reference reset is durable (T1); that asymmetry, not any safety assertion, is the structural reading of why one class of intervention is comfortable and another is not.

The loop rejects what fights its operating point

The hemodynamic package established two locked results about the defended mean arterial pressure. First, essential hypertension is an integral-controller setpoint reset: the defended pressure moves up by 20 mmHg and an intervention applied at the operating point is opposed back to that reset reference, so its durable effect collapses to 0 mmHg even though its transient effect was 15 mmHg (research target RP4). Second, an intervention applied at the reference itself — lowering the renal pressure-natriuresis / RAAS setpoint — is durable, with a 17 mmHg lasting drop (target T1). The kidney is a Guyton infinite-gain integrator, so it rejects sustained operating-point error exactly the way an integral controller must.

That rejection is the structural origin of the side-effect class

The reflex that opposes an operating-point antagonist — baroreflex tachycardia, renin escape, fluid retention — is the homeostatic counter-regulation the loop is built to mount. Read structurally, that counter-regulation is the antihypertensive side-effect class: it is not an accident of a particular molecule but the loop doing its job against an input it experiences as a disturbance. A direction that instead lowers the loop’s own reference is not experienced as a disturbance, so the loop has no error to reject and mounts no counter-regulation. This is the same logic the analgesic whitepaper used to distinguish a threshold-raising lever from a transient block.

The comfort reading — a structural prediction, not a safety result

“Comfort” here is a precise structural statement: a reference-reset direction provokes no counter-regulation, so it does not summon the reflex burden that an operating-point push does. This is a property of where on the loop the lever acts, read off the proven RP4/T1 asymmetry. It is graded [V] as a structural direction. It is emphatically not a tolerability or safety claim about any molecule — those remain open [O] and are firewalled in §20. The three lever pages that follow map each axis onto this principle, and the proposal, prioritisation, falsification and firewall pages bound it.

Cited literature

  1. Imported technique: Non-opioid analgesic threshold logic v2.0, three-lever intervention frame (Zenodo concept DOI 10.5281/zenodo.20733420).
  2. Guyton AC. Renal pressure-natriuresis and the integral control of arterial pressure (infinite-gain integrator).